Revvity (RVTY) Cash from Investing Activities Growth (3y) (2012 - 2026)
Revvity (RVTY) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -188.86% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 2.46% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 0.00% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 13.86% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -59.07% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -48.84% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 64.36% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 41.86% |
| 10 | Revvity | 12.81 Bn | 11.95 Bn | 387.66 Mn | 28.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 28.61% |
| Dec 28, 2025 | -79.08% |
| Mar 30, 2025 | 49.18% |
| Sep 29, 2024 | 30.25% |
| Jun 30, 2024 | 55.23% |
| Mar 31, 2024 | 65.98% |
| Dec 31, 2023 | 0.61% |
| Oct 1, 2023 | 175.40% |
| Jul 2, 2023 | -186.95% |
| Apr 2, 2023 | -113.78% |
| Jan 1, 2023 | 191.37% |
| Apr 3, 2022 | -18.47% |
| Oct 3, 2021 | -644.46% |
| Jul 4, 2021 | -72.75% |
| Apr 4, 2021 | -169.23% |
| Jan 3, 2021 | 37.45% |
| Oct 4, 2020 | -35.66% |
| Jul 5, 2020 | -27.79% |
| Apr 5, 2020 | 44.65% |
| Dec 29, 2019 | -52.87% |